Efficacy/effectiveness Coverage Administration Modeling All age groups Mumps Measles Rubella
Efficacy/effectiveness All age groups Measles Mumps Rubella COVID-19
Vaccine/vaccination All age groups COVID-19 Measles Mumps Rubella
Modeling All age groups Tuberculosis
Efficacy/effectiveness Safety Newborn (0-1 years) Adolescents (10-18 years) Adults (18+) Tuberculosis
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
meeting agenda Agenda & Minutes United Kingdom Ebola Yellow fever Influenza Tuberculosis Human papillomavirus (HPV)
Download:
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download:
Efficacy/effectiveness Safety Coverage All age groups Canada Tuberculosis
Coverage Newborn (0-1 years) Children (2-9 years) Mumps Diphtheria Tetanus Pertussis Measles Rubella Poliomyelitis